Targeted chemotherapy with encapsulated, genetically modified cells engineered to produce CYP2B1, an ifosfamide converting enzyme
2008 ◽
Vol 86
(6)
◽
pp. 679-684
◽
2005 ◽
Vol 16
(3)
◽
pp. 583-591
◽
2001 ◽
Vol 28
(5-6)
◽
pp. 433-440
◽
1982 ◽
Vol 118
(4)
◽
pp. 232-233
◽
2003 ◽
Vol 2
(1)
◽
pp. 13
2007 ◽
Vol 19
(4)
◽
pp. 164-165
2001 ◽
Vol 103
(4)
◽
pp. 255-258
◽
Keyword(s):